GE HealthCare
GE HealthCare Technologies, Inc. is an American multinational medical technology company headquartered in Chicago, Illinois. It was spun-off from General Electric on January 4, 2023, with GE retaining 10.24%. As of 2017, it is a manufacturer and distributor of diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures. It offers dyes used in magnetic-resonance-imaging procedures; manufactures medical diagnostic equipment, including CT image machines; MRI, XRAY; Ultrasound; Cath Labs; Mammogram; Nuclear Medicine Cameras; and develops Health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing. It was incorporated in 1994 and operates in more than 100 countries.
Headquarters at Heller International Building in Chicago | |
| Company type | Public |
|---|---|
Traded as |
|
| Industry | Healthcare |
| Founded |
|
| Headquarters | Heller International Building, Chicago, Illinois , United States |
Area served | Worldwide |
Key people |
|
| Revenue | US$19.6 billion (2023) |
| US$2.4 billion (2023) | |
Net income | US$1.6 billion (2023) |
| Total assets | US$32.5 billion (2023) |
| Total equity | US$7.2 billion (2023) |
| Owner | GE Aerospace (10.24%) |
Number of employees | c. 51,000 (2023) |
| Website | gehealthcare |
| Footnotes / references | |
On November 9, 2021, General Electric announced it would split into three investment-grade public companies, with GE HealthCare being one of the three planned divestitures. GE HealthCare completed its spin-off on January 4, 2023, with the company being listed on the Nasdaq Stock Market.